Ipamorelin is a short peptide sequence that selectively binds to the ghrelin/growth hormone secretagogue receptor. It is recognized as one of the most selective growth hormone (GH) secretagogues, showing no effect on the release of ACTH, prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or cortisol in laboratory studies [1]. Due to its high specificity, ipamorelin has garnered interest both as a therapeutic agent and as a model peptide for investigating the mechanisms behind selective GH receptor binding. It plays a crucial role in the growth and repair of musculoskeletal tissues.